Practo, a digital healthcare platform, plans to hit $1 billion in yearly gross merchandise value (GMV) by June 2026.
Merck has revealed a historic deal with the American government meant to increase prescription drug access for American consumers while simultaneously lowering costs.
The Most Favoured Nation (MFN) drug pricing policy proposed in the United States is not expected to have an immediate impact on Indian pharmaceutical companies, according to industry analysts and market experts. The policy seeks to align US prescr...
.png)
Lupin Limited, a global pharma company, announced today that the Committee for Medicinal Products to Human Use (CHMP) of the European Medicines Agency had given a positive opinion. The opinion suggests that Lupin marketing authorization be...
AstraZeneca and Daiichi Sankyo received FDA approval for Enhertu as a first?line therapy for HER2-positive metastatic breast cancer, altering treatment for newly diagnosed patients.The ruling will allow the use of Enhertu with Perjeta developed...
Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd & CEO, Venus Medicine Research Centre, engaged in a conversation with Thiruamuthan, Assistant Editor at India Pharma Outlook, discusses how India is working to improve rare diseas
Alembic Pharmaceuticals has received final FDA approval for its Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, a generic version of the branded eye treatment Zylet. This achievement enhances the pipeline of U.S. generics at the...
Maharashtra’s Food and Drug Administration (FDA) has cancelled more than 200 licences of medical retailers and wholesalers for supplying low-grade medicines, Minister of State for FDA Narhari Zirwal informed the state assembly on Wednesd..
Big news today from Venus Remedies, as the company confirmed receiving the final Rs 11 crore milestone from Cipla for its novel AMR-focused anti-infective. This marks the completion of all commercial milestones agreed under their 2019 deal...
Trivitron Healthcare and ResoHealth have established a joint venture called Trivitron Digital.AI (TDAI), which is a cutting-edge digital health initiative designed to address the existing adoption gaps on a large scale
, CDSCO.jpg)